Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Femmy Nurul Akbar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Hari Hendarto

    5 shared publications
  • Hari Hendarto

    Department of Internal Medicine, Faculty of Medicine, Syarif Hidayatullah State Islamic University (UIN) Jakarta

    4 shared publications
  • Ainaya Hanif Nabila

    Medical Study Program, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang, Indonesia

    2 shared publications
  • Amaliya Mata’uL Hayah

    Department of Internal Medicine, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang, Indonesia

    2 shared publications
  • Amira Calista Patria

    Medical Study Program, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang, Indonesia

    2 shared publications
  • Fika Ekayanti

    Department of Community Medicine, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang 15419, Banten, Indonesia

    2 shared publications

Latest Publications

  • Open Access

    Prevalence and patterns of chronic non-communicable disease multimorbidity in an Indonesian adult population

    by Hoirun Nisa, Hari Hendarto, Femmy Nurul Akbar, Silvia Nasution, Lilik Zuhriyah

    Background: Chronic non-communicable diseases (NCDs) are a global health challenge, with increasing prevalence of multimorbidity. Objective: This study was to examine the prevalence of chronic NCDs and their multimorbidity patterns in the Indonesian adult population. Methods: Data were extracted from the Indonesian Family Life Survey wave 5 (IFLS-5) and included 17,958 participants aged at least 35 years. Information on 14 chronic NCDs was self-reported to estimate the prevalence of chronic NCDs and multimorbidity. Descriptive statistics were employed to explore the patterns of chronic NCDs multimorbidity, and chi-square tests were used to examine the relationships of age and gender with chronic NCDs multimorbidity. Results: Of all participants, 4,537 (25.3%) participants had one chronic NCD, and 2,749 (15.3%) participants had chronic NCDs multimorbidity. The chronic NCD multimorbidity prevalence increased with advancing age, from 8.6% in individuals age 35-44 years to 25.0% age 65-74 years. Women had a significantly higher multimorbidity of chronic NCDs compared to men. Hypertension (19.1%) was the most prevalent NCDs and appeared in various multimorbidity patterns. The most prevalent of a two-disease combination was hypertension and arthritis, and the most prevalent of a three-disease combination was hypertension, arthritis, and stomach or digestive diseases. Conclusion: The prevalence of chronic NCDs and their multimorbidity is quite high in Indonesian adults, with a complex pattern of multimorbidity. Hypertension occurs in various patterns of multimorbidity. These findings add to the importance of health management and clinical guidelines that focus not only on one chronic NCD but also on various chronic NCD multimorbidity conditions in Indonesian adults. Keywords. Chronic diseases; NCDs; Multimorbidity; Adult, Indonesia

  • Open Access

    Diagnostic challenges of clinically significant portal hypertension in geriatric metabolic dysfunction-associated fatty liver disease: A case report

    by Femmy Nurul Akbar, Nikko Darnindro, Annisa Ayu Wardhani, Safira Rosiana Choirida, Shafa Nada Saphira, Griffith Ismed, Ida Ayu Made Kshanti, Syifa Mustika, Hari Hendarto

    BACKGROUND Metabolic dysfunction-associated fatty liver disease (MAFLD) may progress to cirrhosis and lead to serious complications. Lipid accumulation, hepatocellular ballooning, and sinusoidal endothelial dysfunction increase intrahepatic vascular resistance, resulting in early clinically significant portal hypertension (CSPH). Although hepatic venous pressure gradient (HVPG) remains the gold standard, decompensated cirrhosis may yield deceptively low values. Transient elastography and platelet count provide supportive diagnostic evidence, yet obesity can overestimate disease severity. This report highlights the diagnostic challenge of CSPH, especially MAFLD in geriatric patients. CASE SUMMARY A 78-year-old woman with class I obesity, type 2 diabetes mellitus, and dyslipidemia presented with hematemesis and melena for a three-day period. A prior computed tomography scan revealed moderate diffuse hepatic steatosis, splenic vein dilatation, and splenomegaly. On admission, she presented with pallor, epigastric tenderness, splenomegaly, and mild ascites. Laboratory findings showed anemia, thrombocytopenia, hypoalbuminemia, and hyperglycemia. Abdominal ultrasound confirmed chronic liver disease with splenomegaly. Esophagogastroduodenoscopy demonstrated grade II-III esophageal varices and portal hypertensive gastropathy. Noninvasive fibrosis assessments (non-alcoholic fatty liver disease fibrosis score, aspartate transaminase-to-platelet ratio index, fibrosis-4 index, and FibroScan: E = 28 kPa, controlled attenuation parameter = 191 dB/m) indicated advanced hepatic fibrosis. HVPG measurement was not performed, however due to the Baveno VII criteria (transient elastography ≥ 25 kPa and platelet count < 150 × 109/L), confirmed the diagnosis of CSPH. The patient received endoscopic variceal ligation, a nonselective beta-blocker, a proton pump inhibitor, insulin, a sodium-glucose cotransporter 2 inhibitor, and lifestyle modification, resulting in clinical improvement. CONCLUSION Early and precise evaluation of CSPH in geriatric MAFLD requires an integrated clinical assessment to optimize diagnosis, management, and improve outcomes.

  • Open Access

    Association between coffee consumption and psychological stress with gastroesophageal reflux disease among Indonesian medical students

    by Femmy Nurul Akbar, Intan Nurjannah, Amira Calista Patria, Ainaya Hanif Nabila, Amaliya Mata’uL Hayah, Regina Stefani Anwar, Sayid Ridho, Hari Hendarto

    Medical students are experiencing gastroesophageal reflux disease (GERD) due to academic demands, dietary factors, such as coffee consumption and psycholog

  • Open Access

    Association between coffee consumption and psychological stress with gastroesophageal reflux disease among Indonesian medical students

    by Femmy Nurul Akbar, Intan Nurjannah, Amira Calista Patria, Ainaya Hanif Nabila, Amaliya Mata’uL Hayah, Regina Stefani Anwar, Sayid Ridho, Hari Hendarto

    Objective Medical students are experiencing gastroesophageal reflux disease (GERD) due to academic demands, dietary factors, such as coffee consumption and psychological stress. This study explored the relationship between coffee consumption, psychological stress, and GERD among medical students. A cross-sectional survey was conducted among 200 students at the Faculty of Medicine, Syarif Hidayatullah State Islamic University Jakarta. Results Results showed that 53% of students consumed coffee, 28% had depression, 42% had anxiety, and 30% experienced psychological stress. GERD was found in 27% of students and was significantly related to drinking more than 3 cups of coffee daily (p=0.015), long-term consumption more than 4 years (p=0.001), instant coffee (p=0.001), depression (p=0.033), anxiety (p=0.010), and psychological stress (p=0.001). However, only psychological stress remained significant in multivariate analysis (p=0.002). The study concludes that psychological stress is the strongest factor linked to GERD, more than anxiety, depression, or coffee habits. Reducing stress and limiting coffee may help lower GERD risk among students.

  • Open Access

    Efficacy of therapeutic-dose heparin for severe COVID-19 patients at COVID-19 Emergency Hospital Jakarta

    by Hari Hendarto, Femmy Nurul Akbar, Prasetyo Widhi Buwono, Putri Adara Yasmin, Mega Halida, Efriadi Ismail, Nurul Rakhmawati, Hilman Tadjoedin

    Introduction: Arterial and venous thrombotic events in COVID-19 cause significant morbidity and mortality. For optimal thromboprophylaxis treatment for hospitalized patients, especially those with severe COVID-19 symptoms, it is still unclear whether to use full- or therapeutic-dose versus prophylactic-dose anticoagulation therapy. The study aim was to evaluate the efficacy and safety of unfractionated heparin (UFH) for thromboprophylaxis in severe degree of COVID-19. Methodology: In this cross-sectional study, the medical records of 160 COVID-19 patients at the COVID-19 Emergency Hospital Wisma Atlet, Jakarta, from March to August 2021, were collected. The predetermined inclusion criteria for patients were severe COVID-19 infection; age > 18 years; positive D-dimer level > 400 ng/mL; high-flow nasal cannula (HFNC) oxygenation; IMPROVE bleeding risk score < 7; and willingness to participate in the study. The primary outcome was activated partial thromboplastin time (APTT) target achievement, oxygenation changed to nasal cannula or ended with room air, mortality rate, and the principal safety criterion was presence of bleeding. Results: Of 160 subjects, 63.8% were male and 45.6% were aged 45-59 years old. Obesity was the most common comorbidity at 45.6% Among all subjects, 9.4% experienced bleeding, with hematuria being the most frequent type at 66.7%. All subjects released HFNC, and no deaths were reported. Conclusions: It can be concluded that administration of therapeutic doses of heparin in patients with severe COVID-19 had a low risk of bleeding and no patients were reported to have died. However, further investigation is needed to determine the long-term effects of therapeutic doses of anticoagulants.


  • Open Access

    Adverse events following immunization of mRNA-1273 (Moderna) booster vaccine in clerkship students

    by Hari Hendarto, Femmy Nurul Akbar, Narila Mutia Nasir, Endah Wulandari, Hadianti Adlani

    Two-dose primary vaccine administration was the best strategy to reduce the prevalence and severity of COVID-19. Improved immunity and antibody response to the new variant virus by administering a booster vaccine is needed. Health workers are the main priority for administering the mRNA-1273 (Moderna) booster vaccination in Indonesia. This vaccine has high effectiveness, and safety, however, data and evaluation of adverse events following immunization (AEFI) is required. This study aimed to determine the AEFIs of mRNA-1273 booster vaccination in clinical clerkship students as an early adult age group. The research design was a repeated cross-sectional study using purposive sampling technique. There were 214 subjects who met the requirements. Subject filled out an online questionnaire containing evaluation of AEFIs. The most local AEFIs symptoms were pain at the injection site (79.0%), while the common systemic symptoms were headache, drowsiness, weakness, and fever (37.4%; 26.2%; 9.8%; 9.3%). Most AEFIs were felt within 30 minutes to three days. No respondents required hospitalization, experienced anaphylactic shock, became disabled, or died. The AEFIs did not have a significant relationship with gender, history of allergies, co-morbidities, or history of COVID-19. This information is used as a preventive or educational effort to support implementation vaccine in Indonesia.


  • Open Access

    Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

    by Femmy Nurul Akbar, Safira Rosiana Choirida, Ahmad Zaqi Muttaqin, Fika Ekayanti, Hoirun Nisa, Hari Hendarto

    Healthcare visits were reduced during the COVID-19 pandemic, causing disturbances in sustainable MAFLD monitoring. Telemedicine acts to maintain connectivity between patients and healthcare professionals. This review aimed to assess the role of telemedicine in monitoring MAFLD during the pandemic. Databases searched included l PubMed Central and ScienceDirect from 2020 to 2023. Assessment with The Cochrane Risk of Bias for randomized controlled trials (RCTs) and the Newcastle-Ottawa scale for non-RCTs systematic reviews. Meta-analyses employing a random-effect model were performed to determine the pooled mean difference (MD) and p-value. The results showed three RCT and two non-RCT (n = 239) with 56.9% males and a mean age of 51.3 years. The median intervention duration was 5.5 months. The parameters assessed included body weight (BW), body mass index (BMI), waist circumference, liver function (AST/ALT), lipid profile, HbA1c, and others. Meta-analysis revealed that telemedicine had a significant effect on improving outcomes for BW (MD −2.81: 95% CI, −4.11, −1.51, p < 0.0001) and BMI (MD −1.01: 95% CI, −1.47, −0.55, p < 0.0001) compared to standard care, while the AST/ALT levels were not significantly reduced. Some biochemical markers decreased based on the systematic reviews. In conclusion, telemedicine using mobile-based applications could be an option for monitoring lifestyle modification in MAFLD patients facing the COVID-19 pandemic.


  • Open Access

    Telemedicine as an Option of Healthcare Services in monitoring Non Alcoholic Fatty Liver Disease (NAFLD) Patients Facing COVID-19 Pandemic

    by Femmy Nurul Akbar, Safira Rosiana Choirida, Ahmad Zaqi Muttaqin, Fika Ekayanti, Hari Hendarto

    Healthcare visits were reduced during COVID-19 pandemic causing the disturbance of the sustainability in NAFLD monitoring. Telemedicine acts to maintain connectivity between patients and healthcare professionals. This review aimed to assess telemedicine helps to monitoring in NAFLD. The database was searched from The PubMedCentral and ScienceDirect from 2020 to 2023. We assessed the Cochrane Risk of Bias (RoB) for randomized controlled trial (RCT) and the Newcastle-Ottawa scale for non-RCTs systematic reviews. Meta-analyses with random-effects model to determine the pooled mean difference (MD) and p-value. There were three RCT and two non-RCT were included (n=239) with 56.9% males and the mean age was 51.3 years. Median intervention lasted 5.5 months. The parameter were body weight (BW), body mass index (BMI), waist circumference, liver function (AST/ALT), lipid profile and HbA1c. Metaanalysis showed telemedicine had a significant effect on improving outcomes for BW (MD -2.81: 95% CI, -4.11, -1.51, P 0.0001) and BMI (MD -1.01: 95% CI, -1.47, -0.55, P 0.0001) compared to standard care, while the AST/ALT were not significantly reduced. Other laboratory parameter were decreased from systematic reviews. Telemedicine through mobile-based applications could be an option for monitoring body weight and BMI in NAFLD patients facing the pandemic.


  • Open Access

    Obesity, dyslipidemia, and diabetes mellitus as risk factors in cholelithiasis

    by Hari Hendarto, Femmy Nurul Akbar, Jewaqa Brako Muzakki, Regi Azistha Amri, Septian Nindita Adi Nugraha, Hadianti Adlani

    Objectives: Cholelithiasis or gallstones has many risk factors, such as age, sex, obesity, dyslipidemia, and diabetes mellitus (DM). Studies in developing country shown that obesity, dyslipidemia, and DM occurred in 55.0%, 76.0%, and 17.7% of adults with cholelithiasis, respectively. The aim of this study is to know the proportion of cholelithiasis risk factors. Materials & methods: This retrospective study using descriptive cross sectional design performed in one of the largest referral hospital in Jakarta Indonesia. Demographic data, and laboratory examination were collected from medical record. Patients presented with cholelithiasis from the abdominal ultrasonography was enrolled into study. Results: 93 subjects were selected through consecutive sampling, where in 65.8% were female and 77.5% age>40 years. The majority was obese (47.3%) and the obesity grade I was most prevalent. Dyslipidemia was found in 19.3% subjects with proportion of high total cholesterol was 54.5%, high LDL 90.9%, high triglycerides 27.3%, and low HDL 18.2%. DM was found in 15.0% subjects. Random blood glucose had higher proportion, accounting 57.2% with mean 140.67± 89.69 mg/dl. Female and age>40 years had more proportion in cholelithiasis patients. Conclusions: Proportion of cholelithiasis with obesity 47.3%, dyslipidemia 19.3%, and diabetes 15.0%. However, the proportion of obesity, dyslipidemia and diabetes in this study was lower than other studies in Asia or developing countries. Patients with obesity grade I, high LDL and RBG>40 mg/dl should be aware to have cholelithiasis.


  • Open Access

    Correlation between Steatosis Degree and Hypertension Degree in Non-Alcoholic Fatty Liver Disease Patients in Indonesia

    by Femmy Nurul Akbar, Putri Dwi Bralianti, Ridad Thaufiq Akbar, Hari Hendarto

    Non-alcoholic fatty liver disease (NAFLD) has been recognized closely linked to cardiovascular diseases including hypertension. The connection between these conditions can be attributed to lipotoxicity, that induces systemic inflammation by activating the sympathetic nervous system (SNS) and triggers the release of angiotensin II within the renin-angiotensin-aldosterone system (RAAS). This study examined the correlation between degree of steatosis and degree of hypertension in NAFLD patients at Hajj Hospital Jakarta in 2019-2022. A cross-sectional approach was used to analyse the medical record data obtained through consecutive sampling. B-mode abdominal ultrasound examination assessed the degree of steatosis in NAFLD. Blood pressure grading was based on the 2020 International Society of Hypertension (ISH) Global Hypertension Practice Guidelines. The data were processed using Somers’d test to define the correlation between steatosis and hypertension.Of 53 NAFLD subjects, 56.6% were female, and mild steatosis was dominant (54.7%). The proportion of hypertension among NAFLD patients was 39.7%, with a higher prevalence of 61.9% among those aged 50 years or older. Majority of patients were grade I hypertension, whereas all subjects with grade II hypertension exhibited severe steatosis. There was correlation between the degree of hypertension and steatosis patients with NAFLD, with a p-value of 0.029 and a weak correlation coefficient (r= 0.251). This study found a correlation between steatosis and degree of hypertension. It was suggested females aged 50 years or older with grade II hypertension should be screened for fatty liver.